CRISPR in Cancer: Not Quite Ready for Clinical Trials

Researchers provide further proof that CRISPR can augment cancer treatment in the lab, but many barriers remain before clinical trials can be conducted in patients.

from Latest articles from Cancer Therapy Advisor Lung Cancer http://bit.ly/2Mvc76e